Among People With HIV Who Switch From Efavirenz- To Integrase Strand Transfer Inhibitor-Based Therapies, CYP2B6 Genotype Tied To Weight Gain, Study Indicates

Infectious Disease Advisor (9/9, Van Paridon) reports researchers found that among people with HIV “who switched from efavirenz- to integrase strand transfer inhibitor (INSTI)-based therapies, the genotype CYP2B6 was associated with weight gain.” The find...